The original finding
In 1993, Eugene Fama and Kenneth French documented something that rattled Wall Street: between 1926 and 1990, the smallest 10% of U.S. stocks returned roughly 1.5 to 2 percentage points more per year than the largest 10%, after adjusting for risk. They called it the size premium, and it sat alongside the value premium as one of the two pillars of modern factor investing.
The logic was seductive. Small companies are riskier, less researched, harder to trade, and more likely to fail. Investors should be paid extra to hold that risk. For sixty years, the data agreed.
What the numbers actually show
Over the long arc of market history, the gap is real but modest. Using CRSP data from 1926 through 2024, the smallest decile of U.S. stocks compounded at about 11.9% annually versus roughly 10.3% for the largest decile — a 1.6-point edge. But that edge came with noticeably higher volatility, so on a risk-adjusted basis the advantage shrinks.
More importantly, the premium is unevenly distributed. It shows up in a handful of explosive years and disappears for long stretches. From 1982 to 1993, small caps crushed large caps. From 2011 to 2020, they did the opposite.
Why small caps should earn more
Three forces justify a higher expected return:
- Illiquidity. Small stocks are harder to buy and sell in size, so holders demand a premium.
- Information gap. Thousands of small companies have no analyst coverage at all. Mispricings persist longer.
- Survival risk. Small firms are closer to failure. The ones that survive often do so by growing fast.
A portfolio of small caps is, in effect, a bet on entrepreneurial resilience — and resilience has paid, on average, over decades.
The awkward 2010s
Here is where the story gets uncomfortable. From 2011 to 2020, the Russell 2000 (small caps) returned about 11% a year, while the S&P 500 returned about 14% — and the gap was far wider once you include the mega-cap tech leaders. A whole generation of investors watched small caps quietly lag.
The cause was structural: ultra-low interest rates favored long-duration growth stocks, passive indexing funneled money into the largest names, and a wave of zero-revenue tech companies dominated headlines. Size stopped paying when capital was free and concentration was rewarded.
When size wins
Small caps are highly sensitive to interest rates and the business cycle. They tend to outperform sharply in the early stages of a recovery, when cheap money and renewed confidence lift the most fragile companies first. The rallies of 2003, 2009, and late 2020 all featured small caps leading the charge.
They also benefit disproportionately from domestic economic policy, tax cuts, and reshoring trends — levers that matter more to smaller, domestically focused businesses than to multinationals.
The takeaway
The small-cap premium is not a myth, but it is not a free lunch either. It appears over decades, vanishes for years, and carries more bumpiness along the way. For a long-term investor, a 10% to 20% allocation to small caps within the equity sleeve is a reasonable diversifier — not because it will beat every year, but because its returns arrive at different times than the giant index names.
Just don't expect the premium to show up on a schedule. It rewards patience, not prediction.